Evidence map›Paper›PMID 27189286›Full record

Trial reportYonsei medical journal2016

Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis.

Yoon Sok Chung, Dong Jin Chung, Moo Il Kang, In Ju Kim, Jung Min Koh, Yong Ki Min, Han Jin Oh, Il Hyung Park, Yil Seob Lee, Barbara Kravitz and 3 more

Abstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in Yonsei medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yoon Sok ChungDepartment of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.
Dong Jin ChungDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Moo Il KangDepartment of Endocrinology and Metabolism, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
In Ju KimDepartment of Endocrinology and Metabolism, Pusan National University Hospital, Busan, Korea.
Jung Min KohDivision of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Yong Ki MinDivision of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Han Jin OhDepartment of Family Medicine, Cheil General Hospital, College of Medicine, Kwandong University, Seoul, Korea.
Il Hyung ParkDepartment of Orthopedic Surgery, Kyungpook National University Hospital, Daegu, Korea.
Yil Seob LeeGlaxoSmithKline, Seoul, Korea, Korea.
Barbara KravitzGlaxoSmithKline, Collegeville, PA, USA. barbara.g.kravitz@gsk.com.
Brian WaterhouseGlaxoSmithKline, Collegeville, PA, USA.
Lorraine A FitzpatrickGlaxoSmithKline, Collegeville, PA, USA.
Antonio NinoGlaxoSmithKline, Collegeville, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUp to 71% of South Korean postmenopausal women have vitamin D deficiency {serum 25-hydroxyvitamin D [25(OH) D] level <50 nmol/L}. Data on vitamin D supplementation was collected during the screening phase of an efficacy/safety study of denosumab in Korean postmenopausal women with osteoporosis. This report describes the effect of vitamin D supplementation on repletion to 25(OH)D levels ≥50 nmol/L in Korean postmenopausal women with osteoporosis. MATERIALS AND

methodsVitamin D levels of Korean postmenopausal women (60-90 years old) were measured by extracting 25(OH)D₂ and 25(OH)D₃ from serum samples via protein precipitation and using liquid chromatography with tandem mass spectrometry detection. Calibration curves were constructed from the mass chromatograms to obtain total vitamin D levels. Subjects with serum 25(OH)D levels <50 nmol/L were supplemented with 1000 IU of vitamin D tablets during the 2.5-month-long screening period. Dose, frequency, and duration were determined by the investigator. If repletion was achieved (≥50 nmol/L) on retest, subjects were eligible to be rescreened for study entry.

resultsOf 371 subjects screened, 191 (52%) required vitamin D supplementation, and 88% (168 of 191) were successfully repleted. More than half of the subjects (58%) who were successfully repleted received doses of 2000 IU daily. The mean time to successful repletion was 31 days (standard deviation 8.4 days; range 11-48 days).

conclusionSupplementation with daily median doses of 2000 IU vitamin D successfully repleted 88% of Korean postmenopausal women with osteoporosis within 48 days to a serum vitamin D level of 50 nmol/L.

Indexed as

Asian PeopleDietary SupplementsAgedAged, 80 and overBone Density Conservation AgentsDouble-Blind MethodFemaleHumansMiddle AgedOsteoporosis, PostmenopausalPostmenopauseRepublic of KoreaVitamin DVitamin D Deficiency25-hydroxyvitamin DBone Density Conservation AgentsVitamin DKoreanosteoporosispostmenopauseVitamin D

Identifiers

PMID27189286
PMCPMC4951469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.